Long-term urological follow-up of multicystic dysplastic kidneys: Is it still indicated in 2007?

Authors

  • Karen Psooy The Division of Pediatric Urology, Winnipeg Children’s Hospital, Winnipeg, Man.

DOI:

https://doi.org/10.5489/cuaj.53

Abstract

Objective: To determine whether the current indications for the long-term urologicalfollow-up of children with multicystic dysplastic kidneys (MCDKs) are supported by the literature.

Methods: The membership of the Pediatric Urologists of Canada was surveyedto determine if long-term urological follow-up was being performed, and if so, for what indications. A literature search using PubMed, EMBASE and aConference Papers Index was performed to determine whether the indicationslisted were supported by the literature.

Results: A response rate of 72% was achieved for the survey, with most respondentsfollowing children with MCDK long-term. The main indications for long term follow-up were the increased risk of Wilms’ tumour (54%) and hypertension(32%), observation of the contralateral kidney (43%) and involutionof the MCDK (36%). The literature search did not support long-term urological follow-up for any of these indications, provided unilateral MCDK was anisolated genitourinary abnormality. Although it is rare, a primary care physician could monitor for hypertension.

Conclusion: Long-term urological follow-up of children with “simple MCDK”is not supported by the literature, provided the diagnosis has been confirmedwith a follow-up renal ultrasound at 12–24 months. Blood pressure monitoringby a primary care physician is recommended.

Downloads

Download data is not yet available.

Downloads

Published

2012-12-10

How to Cite

Psooy, K. (2012). Long-term urological follow-up of multicystic dysplastic kidneys: Is it still indicated in 2007?. Canadian Urological Association Journal, 1(2). https://doi.org/10.5489/cuaj.53

Issue

Vol. 1 No. 2 (2007): CUAJ June

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.